HC Wainwright & Co. Reiterates Neutral on Adicet Bio
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a Neutral rating on Adicet Bio (NASDAQ:ACET).
September 30, 2024 | 5:37 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HC Wainwright & Co. has reiterated a Neutral rating on Adicet Bio, indicating no change in their outlook for the company.
The reiteration of a Neutral rating by HC Wainwright & Co. suggests that there is no significant change in the analyst's outlook on Adicet Bio. This typically indicates that the stock is expected to perform in line with the market, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100